Product Pipeline

(As of September 2025)

Development Pipelines

Product code Target Indication Dosage Form Development region Current Phase
M6050C Acne vulgaris Topical JP Approved
M5250E Pruritus with atopic dermatitis (infant) Injection JP PⅢ
M6100 Atopic dermatitis Topical JP PⅢ
M6050F Axillary osmidrosis Topical JP PⅡ
M6120 Chronic spontaneous urticaria Oral JP PⅡ